Bioinformatics analyses combined microarray identify the desregulated MicroRNAs in lung cancer

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 11, 2013, Pages 1509-1516

  Guo, W G ^a   Zhang, Y ^a   Ge, D ^a   Zhang, Y X ^a   Lu, C L ^a   Wang, Q ^a   Fan, H ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Differential expression analysis; MicroRNA; Pathway analysis; Target genes

Indexed keywords

MICRORNA; EPIDERMAL GROWTH FACTOR RECEPTOR; MIRN339 MICRORNA, HUMAN; RASSF1 PROTEIN, HUMAN; RECEPTOR TYROSINE PROTEIN KINASE ERBB 4; RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BIOINFORMATICS; CANCER GROWTH; CONTROLLED STUDY; DATA BASE; GENE EXPRESSION; GENE TARGETING; HYPOXIA; KRAS GENE; LUNG CANCER; LUNG PARENCHYMA; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; ONCOGENE; PROTEIN PROTEIN INTERACTION; RASSF1 GENE; TUMOR SUPPRESSOR GENE; BIOLOGY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG TUMOR; PHYSIOLOGY;

COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR SUPPRESSOR PROTEINS;

EID: 84883482876     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. JEMAL A, SIEGEL R, WARD E, HAO Y, XU J, MURRAY T, THUN MJ. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96. (Pubitemid 351521864)
2. SCOTT WJ, HOWINGTON J, FEIGENBERG S, MOVSAS B, PISTERS K. Treatment of non-small cell lung cancer stage i and stage ii*. Chest 2007;132:234S-242S.
3. HENSCHKE CI, YANKELEVITZ DF, MIRTCHEVA R, MCGUINNESS G, MCCAULEY D, MIETTINEN OS. Ct screening for lung cancer. Am J Roentgenol 2002; 178: 1053-1057.
4. LEE RC, FEINBAUM RL, AMBROS V. The c. Elegans heterochronic gene lin-4 encodes small rnas with antisense complementarity to lin-14. Cell 1993; 75: 843-854. (Pubitemid 24014542)
5. CALIN GA, CROCE CM. Microrna signatures in human cancers. Nature Reviews Cancer 2006; 6: 857-866. (Pubitemid 44629897)
6. ZHANG B, PAN X, COBB GP, ANDERSON TA. Micrornas as oncogenes and tumor suppressors. Develop Biol 2007; 302: 1-12. (Pubitemid 46096921)
7. GARZON R, CALIN GA, CROCE CM. Micrornas in cancer. Ann Rev Med 2009; 60: 167-179.
8. YANAIHARA N, CAPLEN N, BOWMAN E, SEIKE M, KUMAMOTO K, YI M, STEPHENS RM, OKAMOTO A, YOKOTA J, TANAKA T. Unique microrna molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189-198. (Pubitemid 43357945)
9. LU J, GETZ G, MISKA EA, ALVAREZ-SAAVEDRA E, LAMB J, PECK D, SWEET-CORDERO A, EBERT BL, MAK RH, FERRANDO AA, DOWNING JR, JACKS T, HORVITZ HR, GOLUB TR. Microrna expression profiles classify human cancers. Nature 2005; 435: 834-838. (Pubitemid 40839735)
10. ROSENFELD N, AHARONOV R, MEIRI E, ROSENWALD S, SPECTOR Y, ZEPENIUK M, BENJAMIN H, SHABES N, TABAK S, LEVY A. Micrornas accurately identify cancer tissue origin. Nat Biotechnol 2008; 26: 462-469. (Pubitemid 351501813)
11. GLEAVE ME, MONIA BP. Antisense therapy for cancer. Nat Rev Cancer 2005;5: 468-479 (Pubitemid 40791489)
12. KELLER A, LEIDINGER P, BORRIES A, WENDSCHLAG A, WUCHERPFENNIG F, SCHEFFLER M, HUWER H, LENHOF HP, MEESE E. Mirnas in lung cancer-studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer 2009; 9: 353.
13. TROYANSKAYA O, CANTOR M, SHERLOCK G, BROWN P, HASTIE T, TIBSHIRANI R, BOTSTEIN D, ALTMAN RB. Missing value estimation methods for DNA microarrays. Bioinformatics 2001; 17: 520-525. (Pubitemid 32600498)
14. FUJITA A, SATO JR, RODRIGUES LDE O, FERREIRA CE, SOGAYAR MC. Evaluating different methods of microarray data normalization. BMC Bioinformatics 2006; 7: 469.
15. LEWIS BP, SHIH I, JONES-RHOADES MW, BARTEL DP, BURGE CB. Prediction of mammalian microrna targets. Cell 2003; 115: 787-798. (Pubitemid 38058492)
16. JOHN B, ENRIGHT AJ, ARAVIN A, TUSCHL T, SANDER C, MARKS DS. Human microrna targets. PLoS Biol 2004; 2: e363.
17. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, Da Piedade I, Gunsalus KC, Stoffel M. Combinatorial microrna target predictions. Nat Genet 2005; 37: 495-500. (Pubitemid 40617277)
18. SZKLARCZYK D, FRANCESCHINI A, KUHN M, SIMONOVIC M, ROTH A, MINGUEZ P, DOERKS T, STARK M, MULLER J, BORK P, JENSEN LJ, VON MERING C. The string database in 2011: Functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 2011; 39: D561-568.
19. SHANNON P, MARKIEL A, OZIER O, BALIGA NS, WANG JT, RAMAGE D, AMIN N, SCHWIKOWSKI B, IDEKER T. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13: 2498-2504. (Pubitemid 37428274)
20. HUANG DA W, SHERMAN BT, LEMPICKI RA. Systematic and integrative analysis of large gene lists using david bioinformatics resources.Nat Protoc 2009; 4: 44-57.
21. ALAKWAA FM, SOLOUMA NH, KADAH YM. Construction of gene regulatory networks using biclustering and bayesian networks. Theor Biol Med Model 2011; 8: 39.
22. RAMASWAMY S, TAMAYO P, RIFKIN R, MUKHERJEE S, YEANG CH, ANGELO M, LADD C, REICH M, LATULIPPE E, MESIROV JP. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci 2001; 98: 15149.
23. XIONG S, ZHENG Y, JIANG P, LIU R, LIU X, CHU Y. Microrna- 7 inhibits the growth of human non-small cell lung cancer a549 cells through targeting bcl- 2. Int J Biol Sci 2011; 7: 805-814.
24. NOHATA N, HANAZAWA T, ENOKIDA H, SEKI N. Microrna- 1/133a and microrna-206/133b clusters: Dysregulation and functional roles in human cancers. Oncotarget 2012; 3: 9-21.
25. UEDA R, KOHANBASH G, SASAKI K, FUJITA M, ZHU X, KASTENHUBER ER, MCDONALD HA, POTTER DM, HAMILTON RL, LOTZE MT. Dicer-regulated micrornas 222 and 339 promote resistance of cancer cells to cytotoxic t-lymphocytes by down-regulation of icam- 1. Proc Natl Acad Sci 2009; 106: 10746-10751.
26. WU ZS, WU Q, WANG CQ, WANG XN, WANG Y, ZHAO JJ, MAO SS, ZHANG GH, ZHANG N, XU XC. MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis. BMC Cancer 2010; 10: 542.
27. ZHOU C, LIU GB, WANG LJ, LU YX, YUAN L, ZHENG L, CHEN F, PENG FL, LI XN. MiR-339-5p Regulates the Growth, Colony Formation and Metastasis of Colorectal Cancer Cells by Targeting PRL-1. Plos One 2013; 8: e63142.
28. DAMMANN R, LI C, YOON JH, CHIN PL, BATES S, PFEIFER GP. Epigenetic inactivation of a ras association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000; 25: 315-319. (Pubitemid 30437320)
29. LERMAN MI, MINNA JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: Identification and evaluation of the resident candidate tumor suppressor genes. The international lung cancer chromosome 3p21.3 tumor suppressor gene consortium. Cancer Res 2000; 60: 6116-6133.
30. Donninger H, Vos MD, Clark GJ. The rassf1a tumor suppressor. J Cell Sci 2007; 120: 3163-3172. (Pubitemid 350018407)
31. AGATHANGGELOU A, HONORIO S, MACARTNEY DP, MARTINEZ A, DALLOL A, RADER J, FULLWOOD P, CHAUHAN A, WALKER R, SHAW JA, HOSOE S, LERMAN MI, MINNA JD, MAHER ER, LATIF F. Methylation associated inactivation of rassf1a from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 2001; 20: 1509-1518. (Pubitemid 32291201)
32. PFEIFER GP, DAMMANN R. Methylation of the tumor suppressor gene rassf1a in human tumors. Biochemistry (Mosc) 2005; 70: 576-583. (Pubitemid 40920802)
33. VAN DER WEYDEN L, ADAMS DJ. The ras-association domain family (rassf) members and their role in human tumourigenesis. Biochim Biophys Acta 2007; 1776: 58-85. (Pubitemid 47332074)
34. PELOSI G, FUMAGALLI C, TRUBIA M, SONZOGNI A, REKHTMAN N, MAISONNEUVE P, GALETTA D, SPAGGIARI L, VERONESI G, SCARPA A, MALPELI G, VIALE G. Dual role of rassf1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung. Anticancer Res 2010; 30: 4269-4281.
35. KLAPPER LN, KIRSCHBAUM MH, SELA M, YARDEN Y. Biochemical and clinical implications of the erbb/her signaling network of growth factor receptors. Adv Cancer Res 2000; 77: 25-79. (Pubitemid 29439302)
36. SASAKI H, OKUDA K, KAWANO O, ENDO K, YUKIUE H, YOKOYAMA T, YANO M, FUJII Y. Erbb4 expression and mutation in japanese patients with lung cancer. Clin Lung Cancer 2007; 8: 429-433. (Pubitemid 47242442)
37. STARR A, GREIF J, VEXLER A, ASHKENAZY-VOGHERA M, GLADESH V, RUBIN C, KERBER G, MARMOR S, LEV-ARI S, INBAR M, YARDEN Y, BEN-YOSEF R. Erbb4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy. Int J Cancer 2006; 119: 269-274.
38. HOCKEL M, VAUPEL P. Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001; 93: 266-276. (Pubitemid 32219813)
39. YOUNG SD, MARSHALL RS, HILL RP. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci U S A 1988; 85: 9533-9537. (Pubitemid 19027161)
40. BRIZEL DM, SCULLY SP, HARRELSON JM, LAYFIELD LJ, BEAN JM, PROSNITZ LR, DEWHIRST MW. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 1996; 56: 941-943. (Pubitemid 26065381)
41. SUNDFOR K, LYNG H, ROFSTAD EK. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br J Cancer 1998; 78: 822-827. (Pubitemid 28418321)
42. WALENTA S, WETTERLING M, LEHRKE M, SCHWICKERT G, SUNDFOR K, ROFSTAD EK, MUELLER-KLIESER W. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 2000; 60: 916-921. (Pubitemid 30129526)